SSH - BELHAVEN — History
CCN 252003 | 3-year financial timeline | COVID resilience: 54/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+3.3%
Revenue CAGR (3yr)
2.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $19M | $18M | $20M | +7.3% | +3.3% |
| Operating Expenses | $16M | $18M | $19M | +4.8% | +9.0% |
| Operating Margin | 12.9% | 0.6% | 2.9% | +373.5% | -52.4% |
| Net Income | $2M | $0M | $1M | +407.9% | -50.8% |
| Licensed Beds | 25 | 33 | 36 | +9.1% | +20.0% |
| Total Patient Days | 9,530 | 10,640 | 11,312 | +6.3% | +8.9% |
| Medicare Day % | 69% | 64% | 58% | -10.2% | -8.7% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 54/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +6.7% ($19M → $20M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.3%
This Hospital
+7.6%
State Avg
Latest Margin
2.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $20M | -2.1% |
| FY2024 (proj) | $21M | -7.0% |
| FY2025 (proj) | $22M | -12.0% |